Kidswell Bio (TSE:4584) ROC %: -22.66% (As of Mar. 2026)


TSE:4584 Kidswell Bio Corp TSE:4584
48 GF Score
Price 円156.00
GF Value 円233.48
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Kidswell Bio ROC %?

Kidswell Bio TSE:4584 +1.96% 48 ROC % is -22.66% as of Mar. 2026. GuruFocus rates TSE:4584 with a GF Score™ of 48/100 and a GF Value™ of 円233.48 (Possible Value Trap). The stock has 8 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Kidswell Bio's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -22.66%.

As of today (2026-07-05), Kidswell Bio's WACC % is 4.22%. Kidswell Bio's ROC % is -4.16% (calculated using TTM income statement data). Kidswell Bio earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Kidswell Bio  (TSE:4584) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Kidswell Bio's WACC % is 4.22%. Kidswell Bio's ROC % is -4.16% (calculated using TTM income statement data). Kidswell Bio earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Kidswell Bio ROC % Related Terms


Kidswell Bio ROC % Historical Data

* Premium members only.

The historical data trend for Kidswell Bio's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio ROC % Chart

Kidswell Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.05 -26.68 -59.28 0.00 -4.55

Kidswell Bio Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.22 -21.02 12.39 7.61 -22.66
TSE:4584
48GF Score
Kidswell Bio Corp TSE:4584
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kidswell Bio ROC % Calculation

Kidswell Bio's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=-138.508 * ( 1 - 0% )/( (3946.626 + 2138.459)/ 2 )
=-138.508/3042.5425
=-4.55 %

where

Invested Capital(A: Mar. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7008.496 - 680.162 - ( 2995.435 - max(0, 4318.862 - 6700.57+2995.435))
=3946.626

Invested Capital(A: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6088.396 - 655.021 - ( 3294.916 - max(0, 2149.707 - 5840.335+3294.916))
=2138.459

Kidswell Bio's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-707.692 * ( 1 - 3.19% )/( (3909.36 + 2138.459)/ 2 )
=-685.1166252/3023.9095
=-22.66 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5815.129 - 364.266 - ( 1541.503 - max(0, 3039.236 - 5469.461+1541.503))
=3909.36

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6088.396 - 655.021 - ( 3294.916 - max(0, 2149.707 - 5840.335+3294.916))
=2138.459

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -22.66% mean?
Kidswell Bio (TSE:4584) has a ROC % of -22.66% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Kidswell Bio and its competitors.
Is Kidswell Bio's ROC % too high?
Kidswell Bio's current ROC % is -22.66%. Overall, Kidswell Bio has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's ROC % compare to VRTX and REGN?
Kidswell Bio's ROC % of -22.66% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Biotechnology company?
A good ROC % depends on the Biotechnology industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current ROC % is -22.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円233.48, compared to a current price of 円156.00 — trading 33.2% below its estimated fair value. The current ROC % is -22.66%. Kidswell Bio's overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current ROC % is -22.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円156.00 is trading 33.2% below its estimated GF Value™ of 円233.48. GuruFocus considers Kidswell Bio to be Possible Value Trap.

Key valuation signals for TSE:4584:

  • ROC %: -22.66%
  • GF Value™: 円233.48 vs. price of 円156.00 (33.2% below fair value)
  • GF Score™: 48/100 with 8 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
48GF Score

Get the complete analysis for TSE:4584

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円156.00
Price
円233.48
GF Value